These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8281199)

  • 61. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone.
    Burns EC; Tanner JM; Preece MA; Cameron N
    Eur J Pediatr; 1981 Oct; 137(2):155-64. PubMed ID: 7308226
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment of growth hormone deficient patients with recombinant somatropin for 1 year: results of a Chinese multicentre trial.
    Shi YF; Bao XL; Wang DF; Chen RG; Chun Y
    Acta Paediatr Scand Suppl; 1990; 370():212-5. PubMed ID: 2260454
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stepwise evaluation of the short child. With comments on the status of growth hormone therapy.
    Stelling MW
    Postgrad Med; 1986 May; 79(6):185-7, 190-2. PubMed ID: 3085075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Whole body nitrogen kinetics and their relationship to growth in short children treated with recombinant human growth hormone.
    Dempsher DP; Bier DM; Tollefsen SE; Rotwein PS; Daughaday WH; Jensen MC; Galgani JP; Heath-Monnig E; Trivedi B
    Pediatr Res; 1990 Oct; 28(4):394-400. PubMed ID: 2235139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Growth-hormone deficiency in congenital rubella.
    Preece MA; Kearney PJ; Marshall WC
    Lancet; 1977 Oct; 2(8043):842-4. PubMed ID: 72194
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapy of growth hormone deficiency.
    Butenandt O
    Baillieres Clin Endocrinol Metab; 1992 Jul; 6(3):547-55. PubMed ID: 1524551
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Treatment with growth hormone of children with short stature, borne with intrauterine growth retardation].
    Czernichow P
    Arch Pediatr; 1996; 3 Suppl 1():194s-196s. PubMed ID: 8796014
    [No Abstract]   [Full Text] [Related]  

  • 68. Growth response in the first year of growth hormone treatment in prepubertal children with organic growth hormone deficiency: a comparison with idiopathic growth hormone deficiency. The Executive Scientific Committee of the Kabi International Growth Study.
    Price DA; Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1990; 370():131-7; discussion 138. PubMed ID: 2260451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid decrease of urinary pyridinoline excretion in growth hormone deficient children following discontinuation of growth hormone therapy.
    Kuno T; Tasaki H; Miyazaki S; Horie H
    Acta Paediatr Jpn; 1997 Feb; 39(1):18-20. PubMed ID: 9124047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multicentre clinical trial of authentic recombinant somatropin in growth hormone deficiency.
    Bierich JR
    Acta Paediatr Scand Suppl; 1987; 337():135-40. PubMed ID: 3324634
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Growth and body composition in intrauterine growth retardation (IUGR) before and during human growth hormone administration.
    Lee PA; Blizzard RM; Cheek DB; Holt AB
    Metabolism; 1974 Oct; 23(10):913-9. PubMed ID: 4370058
    [No Abstract]   [Full Text] [Related]  

  • 72. Growth hormone treatment and the short child: to treat or not to treat?
    Bercu BB
    J Pediatr; 1987 Jun; 110(6):991-5. PubMed ID: 3295165
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency.
    Zamboni G; Antoniazzi F; Radetti G; Musumeci C; Tatò L
    J Pediatr; 1991 Sep; 119(3):483-5. PubMed ID: 1880667
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of growth hormone on lymphocyte respiration and growth rate of children.
    Kuna GB; Collipp PJ; Katkocin D; Sherwyn J; Amin S; Maddaiah VT
    Metabolism; 1979 Dec; 28(12):1239-43. PubMed ID: 514085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intermittent versus continuous administration of growth hormone treatment.
    Hakeem V; Hindmarsh PC; Brook CG
    Arch Dis Child; 1993 Jun; 68(6):783-4. PubMed ID: 8333773
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Follow-up of antibodies to growth hormone in 210 growth hormone-deficient children treated with different commercial preparations.
    Pirazzoli P; Cacciari E; Mandini M; Cicognani A; Zucchini S; Sganga T; Capelli M
    Acta Paediatr; 1995 Nov; 84(11):1233-6. PubMed ID: 8580617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel dominant negative mutation in the intracellular domain of GHR is associated with growth hormone insensitivity.
    Takagi M; Shinohara H; Nagashima Y; Hasegawa Y; Narumi S; Hasegawa T
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):669-71. PubMed ID: 27234692
    [No Abstract]   [Full Text] [Related]  

  • 78. Regular monitoring of bone age is not useful in children treated with growth hormone.
    Wilson DM
    Pediatrics; 1999 Oct; 104(4 Pt 2):1036-9. PubMed ID: 10506260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Micropenis secondary to growth hormone deficiency: does treatment with growth hormone alone result in adequate penile growth?
    Levy JB; Husmann DA
    J Urol; 1996 Jul; 156(1):214-6. PubMed ID: 8648808
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone.
    Torrado C; Bastian W; Wisniewski KE; Castells S
    J Pediatr; 1991 Sep; 119(3):478-83. PubMed ID: 1831841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.